NEW CBRB DIRECTORS
Imperial’s CBRB appoints new co-directors
Professor Mariagrazia Pizza and Professor Shiranee Sriskandan will lead the Centre for Bacterial Resistance Biology (CBRB).
Stories tagged with 'vaccines'
HUMAN CHALLENGE STUDIES
HIC-Vac: Improving vaccine development through human challenge studies
Professor Peter Openshaw explains how HIC-Vac is developing human challenge studies to improve vaccines against major infections.
Virology and Vaccines
Imperial launches new online courses on virology and vaccinology
A new online Coursera series will explore how viruses infect us, how vaccines protect us and the latest cutting-edge infectious disease research.
Infection studies
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
Vaccine Student Network
Vaccine Chronicles: Experiences from Vaccine Student Research Network Seminar
On 15 January Imperial's Vaccine Student Research Network hosted its first Vaccine Bioscience seminar.
T CELL RESPONSES
T cells may provide more durable protection against Omicron than antibodies
New review suggests T cells are more robust against ‘Omicron breakthroughs’ than antibodies, offering fresh insights for COVID-19 vaccine development.
Cancer therapy
First UK patients receive experimental mRNA therapy for cancer
Cancer patients in the UK are receiving a new therapeutic to help their bodies recognise and fight cancer cells as part of a global trial.
COVID antibody boost
Immunosuppressing medicine can be interrupted to boost COVID-19 vaccine response
Interrupting treatment of immunosuppressing medicines for two weeks can significantly improve antibody immunity provided by COVID-19 booster vaccines.
Future vaccines
£17m awarded to develop globally important vaccine hubs
Imperial researchers will lead two hubs to improve global access to life-saving vaccines.
1
Vaccine Boost
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
